Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)111.28
  • Today's Change-17.52 / -13.60%
  • Shares traded24.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Aug 07 2024 15:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue60,11559,28348,704
OPERATING EXPENSES
Cost of revenue total15,91517,20613,241
Selling, general and admin. expenses, total10,3829,9489,615
Depreciation/amortization------
Unusual expense(income)19,3732,3663,056
Other operating expenses, total------
Total operating expense58,33341,33836,166
Operating income1,78317,94512,538
Other, net918960468
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1,88916,44413,879
Provision for income taxes1,5121,9181,521
Net income after taxes37714,52612,358
Minority interest(12)(7)(13)
Net income before extra. Items36514,51912,345
Total extraordinary items00704
Net income36514,51913,049
Inc.avail. to common excl. extra. Items36514,51912,345
Inc.avail. to common incl. extra. Items36514,51913,049
EPS RECONCILIATION
Basic/primary weighted average shares2,5372,5322,530
Basic/primary eps excl. extra items0.145.734.88
Basic/primary eps incl. extra items0.145.735.16
Dilution adjustment------
Diluted weighted average shares2,5472,5422,538
Diluted eps excl. extra items0.145.714.86
Diluted eps incl. extra items0.145.715.14
COMMON STOCK DIVIDENDS
DPS - common stock primary issue2.962.802.64
Gross dividend - common stock7,5517,1346,715
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1,146962806
SUPPLEMENTAL INCOME
Depreciation, supplemental1,8281,8241,578
Total special items21,4574,3705,238
NORMALISED INCOME
Normalized income before taxes23,34620,81419,117
Effect of special items on income taxes7,237323544
Income tax excluding impact of special items8,7492,2412,065
Normalized income after tax14,59618,57317,052
Normalized income avail. to common14,58418,56617,039
Basic normalized EPS5.757.336.73
Diluted normalized EPS5.737.306.71
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.